Romanian pharma factory Zentiva aims to strengthen position with EUR 9 mln investment

Pharmaceutical company Zentiva Romania, which is celebrating 50 years of production at its factory in Bucharest, has seen exports rising. Exports to important EU markets such as Germany and the UK, have risen to 10 percent of production this year, after “insignificant” exports in 2012. the company wants to increase exports to 50 percent of the local production in the following five years, and invest some EUR 9 million in the unit.

Zentiva, which is controlled by French pharmaceutical group Sanofi, produces drugs such as Algocalmin, Distonocalm and Extraveral. “The contribution to Sanofi Romania from local production is about two-thirds by volume and a quarter by value,” said Zentiva Romania's industrial operations chief Margareta Tănase (in picture). “We intend to strengthen the position of the factory both locally and internationally,” she added. The French Sanofi group is the largest player on the local medicines' market, according to local media, with an annual turnover of around EUR 175 million. editor@romania-insider.com photo source: sxc.hu